UBS maintains Buy on Morgan Stanley, raises target to $255
UBS analyst Erika Najarian maintained a Buy rating on Morgan Stanley and increased the price target to $255 from $214. This follows Evercore ISI Group maintaining an Outperform rating with a target of $233, highlighting positive sentiment from analysts.

*this image is generated using AI for illustrative purposes only.
UBS analyst Erika Najarian has maintained a Buy rating on Morgan Stanley (NYSE: MS) while raising the price target to $255 from the previous $214. This adjustment signals confidence in the financial services firm's valuation and market performance, suggesting potential upside from current trading levels.
The revised target of $255 replaces the earlier estimate of $214 as the firm reassesses the stock's position. This update follows a separate rating action by Evercore ISI Group, where analyst Glenn Schorr maintained an Outperform rating and raised the target to $233 from $210.
Morgan Stanley operates as a global financial services firm, offering services in investment banking, securities, and investment management. The stock is listed on the NYSE under the ticker MS.
| Analyst Firm | Analyst | Rating | Price Target | Previous Target |
|---|---|---|---|---|
| UBS | Erika Najarian | Buy | $255 | $214 |
| Evercore ISI Group | Glenn Schorr | Outperform | $233 | $210 |
The rating updates provide investors with benchmarks for performance expectations, focusing on the company's ability to execute its strategy in the current market environment.
What specific factors are driving the increased confidence in Morgan Stanley's valuation?
How might these price target adjustments influence investor sentiment toward the financial sector?
What are the potential risks that could hinder Morgan Stanley from reaching these revised targets?

































